Skip to main content
Clinical Trials/NCT05594264
NCT05594264
Terminated
Not Applicable

Developing and Implementing a Storytelling Intervention for African Americans Living With Hypertension

University of Delaware1 site in 1 country60 target enrollmentJuly 14, 2022
ConditionsHypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
University of Delaware
Enrollment
60
Locations
1
Primary Endpoint
Blood Pressure
Status
Terminated
Last Updated
last year

Overview

Brief Summary

Narrative communication (e.g., storytelling) is an approach that has contributed to behavioral change for individuals with conditions such as diabetes, breast cancer, and hypertension. The objective of this study is to conduct a feasibility and pilot study storytelling intervention for African Americans with hypertension. In the feasibility phase 30 African Americans with hypertension will be recruited to view nine patient stories and provide feedback on the effectiveness, usefulness, and satisfaction with the stories. Nine African Americans adults with hypertension were filmed, sharing experiences living with and managing hypertension; including, diet and exercise tips, suggestions for locating healthy foods, and motivational stories about successfully controlling hypertension. During the feasibility phase feedback will also be elicited from the participants about the best approaches for delivering a storytelling intervention, and obtain feedback on the resources and health information that would be helpful to an individual participating in a storytelling intervention. In the pilot study phase, 30 African Americans adults with hypertension will be recruited to participate in a 6-week trial, each week the participants will watch one story and review one module of health information accessible through the study specific website developed for the HBPStories study. Data will be collected at baseline and 6-weeks including systolic and diastolic blood pressure, medication adherence, health behaviors such as diet and physical activity, and psychosocial measures including positive affect and self-efficacy in the management of hypertension.

Registry
clinicaltrials.gov
Start Date
July 14, 2022
End Date
June 24, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • The study inclusion criteria are as follows:
  • self-reported hypertension
  • race/ethnicity: Black or African American
  • prescribed antihypertensive medication
  • age ≥ 18 years

Exclusion Criteria

  • The exclusion criteria are:
  • cognitive limitations that limit the ability to provide informed consent
  • unable to speak or read English

Outcomes

Primary Outcomes

Blood Pressure

Time Frame: 6 weeks

Systolic and Diastolic Blood Pressure, Unit of Measure: Percentage of Individuals with Elevated or High Blood Pressure

Medication Adherence

Time Frame: 6 weeks

Self-reported medication adherence, Unit of Measure: Percentage of Individuals reporting low, moderate, or high adherence

Study Sites (1)

Loading locations...

Similar Trials